Hana Pharm Co Ltd
KRX:293480
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
H
|
Hana Pharm Co Ltd
KRX:293480
|
KR |
|
W
|
Waterstone Financial Inc
F:47Z
|
US |
|
A
|
Alpha Real Estate Services SA
ATHEX:ASTAK
|
GR |
|
H-Farm SpA
F:5JQ
|
IT |
|
Rent the Runway Inc
NASDAQ:RENT
|
US |
|
S
|
SCM LifeScience Co Ltd
KOSDAQ:298060
|
KR |
|
T
|
Tirupati Finlease Ltd
BSE:539488
|
IN |
|
WIA Gold Ltd
ASX:WIA
|
AU |
|
Sunjuice Holdings Co Ltd
TWSE:1256
|
CN |
|
Mirum Pharmaceuticals Inc
F:08D
|
US |
|
U
|
UniTest Inc
KOSDAQ:086390
|
KR |
|
M
|
Mabel Ventures Inc
CNSX:MBL
|
CA |
|
S
|
S Net Systems Inc
KOSDAQ:038680
|
KR |
|
P
|
Practical Solution PCL
SET:TPS
|
TH |
|
A
|
Atlas Technologies Corp
TSE:9563
|
JP |
Bankruptcy Probability
Hana Pharm Co Ltd's probability of bankruptcy is Hidden . The solvency score is Hidden .
We take all the information about a company's solvency, such as how easily it can pay interest on outstanding debt, how much cash it has, the amount of debt, and more, and use it to estimate the probability of bankruptcy.
Solvency Ratios
Solvency Ratios Comparison
Hana Pharm Co Ltd Competitors
| Country | Company | Market Cap | D/E | D/A |
Interest Coverage |
Altman Z-Score |
Quick Ratio |
Current Ratio |
Cash Ratio |
||
|---|---|---|---|---|---|---|---|---|---|---|---|
| KR |
H
|
Hana Pharm Co Ltd
KRX:293480
|
146.4B KRW |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Eli Lilly and Co
NYSE:LLY
|
1.2T USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Johnson & Johnson
NYSE:JNJ
|
644.5B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| CH |
|
Roche Holding AG
OTC:RHHBF
|
382.4B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Merck & Co Inc
NYSE:MRK
|
363.5B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| CH |
|
Novartis AG
SIX:NOVN
|
245B CHF |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| UK |
|
AstraZeneca PLC
LSE:AZN
|
198.9B GBP |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| CA |
|
Nuvo Pharmaceuticals Inc
TSX:MRV
|
264.4B CAD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| DK |
|
Novo Nordisk A/S
CSE:NOVO B
|
1.2T DKK |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Pfizer Inc
NYSE:PFE
|
173.4B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Bristol-Myers Squibb Co
NYSE:BMY
|
128.7B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Hana Pharm Co Ltd's probability of bankruptcy is Hidden .
The probability of bankruptcy is estimated using credit risk models that assess financial health, debt levels, interest coverage, and other solvency indicators.
As of the latest report, Hana Pharm Co Ltd has total debt of 63.5B KRW. This includes both short-term (39.9B KRW) and long-term (23.6B KRW) debt.
You can find a full breakdown on its Balance Sheet.